 | • レポートコード：MRC308GR11591 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・生ワクチン、不活化ワクチン
用途別セグメント
・子豚、成豚
主要な市場プレーヤー
・Zoetis Animal Health、Boehringer-Ingelheim、Merck Animal Health、Ceva Santé Animale、MSD Animal Health、SPAH、Nanjing Tianbang Biological Technology、Sichuan Huapai Bio-pharmaceutical、Guangdong Winsun Bio Pharmaceutical、Wuhan Keqian Biology、Shanghai Hile Bio-Technology、Harbin Pharmaceutical Group Bio-Vaccine、Ringpu、Shandong Huahong Bioengineering、Weike Biotechnology、Nanjing Tianbang Biological Technology、China Animal Husbandry Industry
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンメーカーの企業概要、2019年～2022年までの豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンの産業チェーンを掲載しています。
・第14、15章では、豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンの概要
– 種類別分析（2018年vs2022年vs2029年）：生ワクチン、不活化ワクチン
– 用途別分析（2018年vs2022年vs2029年）：子豚、成豚
– 世界の豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチン市場規模・予測
– 世界の豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Zoetis Animal Health、Boehringer-Ingelheim、Merck Animal Health、Ceva Santé Animale、MSD Animal Health、SPAH、Nanjing Tianbang Biological Technology、Sichuan Huapai Bio-pharmaceutical、Guangdong Winsun Bio Pharmaceutical、Wuhan Keqian Biology、Shanghai Hile Bio-Technology、Harbin Pharmaceutical Group Bio-Vaccine、Ringpu、Shandong Huahong Bioengineering、Weike Biotechnology、Nanjing Tianbang Biological Technology、China Animal Husbandry Industry
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：生ワクチン、不活化ワクチン
・用途別分析2018年-2029年：子豚、成豚
・豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Live Vaccine
1.3.3 Inactivated Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Piglets
1.4.3 Adults Pigs
1.5 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size & Forecast
1.5.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (2018-2029)
1.5.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Zoetis Animal Health
2.1.1 Zoetis Animal Health Details
2.1.2 Zoetis Animal Health Major Business
2.1.3 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.1.4 Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Zoetis Animal Health Recent Developments/Updates
2.2 Boehringer-Ingelheim
2.2.1 Boehringer-Ingelheim Details
2.2.2 Boehringer-Ingelheim Major Business
2.2.3 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.2.4 Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer-Ingelheim Recent Developments/Updates
2.3 Merck Animal Health
2.3.1 Merck Animal Health Details
2.3.2 Merck Animal Health Major Business
2.3.3 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.3.4 Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Animal Health Recent Developments/Updates
2.4 Ceva Santé Animale
2.4.1 Ceva Santé Animale Details
2.4.2 Ceva Santé Animale Major Business
2.4.3 Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.4.4 Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ceva Santé Animale Recent Developments/Updates
2.5 MSD Animal Health
2.5.1 MSD Animal Health Details
2.5.2 MSD Animal Health Major Business
2.5.3 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.5.4 MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MSD Animal Health Recent Developments/Updates
2.6 SPAH
2.6.1 SPAH Details
2.6.2 SPAH Major Business
2.6.3 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.6.4 SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 SPAH Recent Developments/Updates
2.7 Nanjing Tianbang Biological Technology
2.7.1 Nanjing Tianbang Biological Technology Details
2.7.2 Nanjing Tianbang Biological Technology Major Business
2.7.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.7.4 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
2.8 Sichuan Huapai Bio-pharmaceutical
2.8.1 Sichuan Huapai Bio-pharmaceutical Details
2.8.2 Sichuan Huapai Bio-pharmaceutical Major Business
2.8.3 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.8.4 Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
2.9 Guangdong Winsun Bio Pharmaceutical
2.9.1 Guangdong Winsun Bio Pharmaceutical Details
2.9.2 Guangdong Winsun Bio Pharmaceutical Major Business
2.9.3 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.9.4 Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
2.10 Wuhan Keqian Biology
2.10.1 Wuhan Keqian Biology Details
2.10.2 Wuhan Keqian Biology Major Business
2.10.3 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.10.4 Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Keqian Biology Recent Developments/Updates
2.11 Shanghai Hile Bio-Technology
2.11.1 Shanghai Hile Bio-Technology Details
2.11.2 Shanghai Hile Bio-Technology Major Business
2.11.3 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.11.4 Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shanghai Hile Bio-Technology Recent Developments/Updates
2.12 Harbin Pharmaceutical Group Bio-Vaccine
2.12.1 Harbin Pharmaceutical Group Bio-Vaccine Details
2.12.2 Harbin Pharmaceutical Group Bio-Vaccine Major Business
2.12.3 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.12.4 Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
2.13 Ringpu
2.13.1 Ringpu Details
2.13.2 Ringpu Major Business
2.13.3 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.13.4 Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Ringpu Recent Developments/Updates
2.14 Shandong Huahong Bioengineering
2.14.1 Shandong Huahong Bioengineering Details
2.14.2 Shandong Huahong Bioengineering Major Business
2.14.3 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.14.4 Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Shandong Huahong Bioengineering Recent Developments/Updates
2.15 Weike Biotechnology
2.15.1 Weike Biotechnology Details
2.15.2 Weike Biotechnology Major Business
2.15.3 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.15.4 Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Weike Biotechnology Recent Developments/Updates
2.16 Nanjing Tianbang Biological Technology
2.16.1 Nanjing Tianbang Biological Technology Details
2.16.2 Nanjing Tianbang Biological Technology Major Business
2.16.3 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.16.4 Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
2.17 China Animal Husbandry Industry
2.17.1 China Animal Husbandry Industry Details
2.17.2 China Animal Husbandry Industry Major Business
2.17.3 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
2.17.4 China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 China Animal Husbandry Industry Recent Developments/Updates
3 Competitive Environment: Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Manufacturer
3.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturer Market Share in 2022
3.5 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Overall Company Footprint Analysis
3.5.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Region Footprint
3.5.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Company Product Type Footprint
3.5.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Region
4.1.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Region (2018-2029)
4.2 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value (2018-2029)
4.3 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value (2018-2029)
4.5 South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Type (2018-2029)
5.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Application (2018-2029)
6.3 Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Country
7.3.1 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Country
8.3.1 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Region
9.3.1 Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Country
10.3.1 South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Size by Country
11.3.1 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Drivers
12.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market Restraints
12.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine
13.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Process
13.4 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Typical Distributors
14.3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Zoetis Animal Health Basic Information, Manufacturing Base and Competitors
Table 4. Zoetis Animal Health Major Business
Table 5. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 6. Zoetis Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Zoetis Animal Health Recent Developments/Updates
Table 8. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer-Ingelheim Major Business
Table 10. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 11. Boehringer-Ingelheim Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer-Ingelheim Recent Developments/Updates
Table 13. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 14. Merck Animal Health Major Business
Table 15. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 16. Merck Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck Animal Health Recent Developments/Updates
Table 18. Ceva Santé Animale Basic Information, Manufacturing Base and Competitors
Table 19. Ceva Santé Animale Major Business
Table 20. Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 21. Ceva Santé Animale Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Ceva Santé Animale Recent Developments/Updates
Table 23. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 24. MSD Animal Health Major Business
Table 25. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 26. MSD Animal Health Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. MSD Animal Health Recent Developments/Updates
Table 28. SPAH Basic Information, Manufacturing Base and Competitors
Table 29. SPAH Major Business
Table 30. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 31. SPAH Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. SPAH Recent Developments/Updates
Table 33. Nanjing Tianbang Biological Technology Basic Information, Manufacturing Base and Competitors
Table 34. Nanjing Tianbang Biological Technology Major Business
Table 35. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 36. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 38. Sichuan Huapai Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Sichuan Huapai Bio-pharmaceutical Major Business
Table 40. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 41. Sichuan Huapai Bio-pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
Table 43. Guangdong Winsun Bio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Guangdong Winsun Bio Pharmaceutical Major Business
Table 45. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 46. Guangdong Winsun Bio Pharmaceutical Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
Table 48. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Keqian Biology Major Business
Table 50. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 51. Wuhan Keqian Biology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Keqian Biology Recent Developments/Updates
Table 53. Shanghai Hile Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 54. Shanghai Hile Bio-Technology Major Business
Table 55. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 56. Shanghai Hile Bio-Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Shanghai Hile Bio-Technology Recent Developments/Updates
Table 58. Harbin Pharmaceutical Group Bio-Vaccine Basic Information, Manufacturing Base and Competitors
Table 59. Harbin Pharmaceutical Group Bio-Vaccine Major Business
Table 60. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 61. Harbin Pharmaceutical Group Bio-Vaccine Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
Table 63. Ringpu Basic Information, Manufacturing Base and Competitors
Table 64. Ringpu Major Business
Table 65. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 66. Ringpu Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Ringpu Recent Developments/Updates
Table 68. Shandong Huahong Bioengineering Basic Information, Manufacturing Base and Competitors
Table 69. Shandong Huahong Bioengineering Major Business
Table 70. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 71. Shandong Huahong Bioengineering Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Shandong Huahong Bioengineering Recent Developments/Updates
Table 73. Weike Biotechnology Basic Information, Manufacturing Base and Competitors
Table 74. Weike Biotechnology Major Business
Table 75. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 76. Weike Biotechnology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Weike Biotechnology Recent Developments/Updates
Table 78. Nanjing Tianbang Biological Technology Basic Information, Manufacturing Base and Competitors
Table 79. Nanjing Tianbang Biological Technology Major Business
Table 80. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 81. Nanjing Tianbang Biological Technology Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 83. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 84. China Animal Husbandry Industry Major Business
Table 85. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Product and Services
Table 86. China Animal Husbandry Industry Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. China Animal Husbandry Industry Recent Developments/Updates
Table 88. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Doses)
Table 89. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 91. Market Position of Manufacturers in Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Production Site of Key Manufacturer
Table 93. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Company Product Type Footprint
Table 94. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Market: Company Product Application Footprint
Table 95. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine New Market Entrants and Barriers to Market Entry
Table 96. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 98. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 99. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 102. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 103. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 104. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 105. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 108. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 109. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 110. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 111. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 112. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 113. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 114. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 115. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 116. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 117. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 118. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 119. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 120. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 121. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 124. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 125. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 126. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 127. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 128. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 129. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 132. Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 133. Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 134. Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 135. Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 136. Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 137. Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 140. South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 141. South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 142. South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 143. South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 144. South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 145. South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 148. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 149. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 150. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 151. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 152. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 153. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 155. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Raw Material
Table 156. Key Manufacturers of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Raw Materials
Table 157. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Typical Distributors
Table 158. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Typical Customers
List of Figures
Figure 1. Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Picture
Figure 2. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Live Vaccine Examples
Figure 5. Inactivated Vaccine Examples
Figure 6. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Piglets Examples
Figure 9. Adults Pigs Examples
Figure 10. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity (2018-2029) & (K Doses)
Figure 13. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 14. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 29. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 32. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea and Porcine Rotavirus Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Swine Transmissble Gastroenteritis,Porcine Epidemic Diarrhea